Genmab A/S (GMAB)
NASDAQ: GMAB · Real-Time Price · USD
56.49
-0.80 (-1.40%)
At close: Oct 29, 2026, 4:00 PM EDT
56.60
+0.11 (0.19%)
After-hours: Oct 29, 2026, 5:01 PM EDT
Genmab Market Cap
Genmab has a market cap or net worth of $33.33 billion as of October 29, 2026. Its market cap has increased by 78.98% in one year.
Market Cap
33.33B
Enterprise Value
37.01B
1-Year Change
78.98%
Global Rank
n/a
Country Rank
n/a
Category
ChartMarket Cap Chart
Since April 23, 2012, Genmab's market cap has increased from $420.50M to $33.33B, an increase of 7,826.93%. That is a compound annual growth rate of 35.13%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 28, 2026 | 35.72B | 80.64% |
| Dec 31, 2025 | 19.78B | 43.19% |
| Dec 31, 2024 | 13.81B | -34.35% |
| Dec 29, 2023 | 21.04B | -24.60% |
| Dec 30, 2022 | 27.90B | 7.47% |
| Dec 31, 2021 | 25.96B | -1.89% |
| Dec 31, 2020 | 26.46B | 84.27% |
| Dec 31, 2019 | 14.36B | 35.31% |
| Dec 31, 2018 | 10.61B | -0.44% |
| Dec 29, 2017 | 10.66B | -0.04% |
| Dec 30, 2016 | 10.66B | 23.74% |
| Dec 31, 2015 | 8.62B | 128.70% |
| Dec 31, 2014 | 3.77B | 49.72% |
| Dec 31, 2013 | 2.52B | 179.56% |
| Dec 31, 2012 | 900.30M | 114.10% |
| Apr 23, 2012 | 420.50M | - |
View and export this data all the way back to 2012. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| argenx SE | 55.53B |
| BeOne Medicines AG | 42.45B |
| Revolution Medicines | 40.45B |
| Royalty Pharma | 37.27B |
| Alnylam Pharmaceuticals | 31.10B |
| Roivant Sciences | 26.81B |
| Incyte | 23.69B |
| BioNTech SE | 22.10B |